spacer
home > epc > summer 2002 > clinical trials in bulgaria
PUBLICATIONS
European Pharmaceutical Contractor

Clinical Trials in Bulgaria

Being a typical Eastern European country, Bulgaria has been kept apart from mainstream clinical research for a long time. This isolation was based on the perception that either to work under the conditions of Bulgaria's political regimen was undesirable, or its sequential economic and respectively clinical standards were not reliable enough to meet the high GCP requirements.

However, this perception is quite likely to be fading away with time, in light of the democratic changes in Central and Eastern Europe. Bulgaria was 'discovered' by the pharmaceutical companies and contract research organisations (CROs) in 1995. Medical departments of most large and mid-sized companies were established, many CROs increased their activity in Bulgaria, and some of them opened local offices there.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Milen Vrabevski, Medical Director of Comac Medical Ltd., in Sofia, Bulgaria

Dr Milen Vrabevski is Medical Director of Comac Medical Ltd., a full service small CRO based in Sofia, Bulgaria. He has over five years of experience in the pharmaceutical industry, mainly in the field of clinical research.

After graduating from the Medical University of Varna in 1995, Milen began his career working as a Junior Doctor in a surgery department, and then as a Medical Representative of a pharmaceutical company before founding Comac Medical Ltd. in 1997, assuming the position of Director.

Being one of the pioneers in the GCP and Quality of Life (QoL) area in his country, Milen has participated in conducting all company clinical studies and QoL projects.


spacer
Dr Milen Vrabevski
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Clinical Trial Supply West Coast Conference 2019

Philadelphia, USA – April 24, 2019. This year’s Clinical Trial Supply West Coast Conference will see leading biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) showcasing its specialist clinical trials expertise in relation to scheduled drugs.
More info >>

White Papers

Tabletability, Compactability, and Compressibilty: What’s the Difference?

Natoli Engineering Company, Inc.

To patients and consumers, tablets are a simple and convenient dosage form. But the science behind compressing a block of particles or granules into a single tablet can be complicated. That’s where common compression studies can help. This article explains how to develop tabletability, compactibility, and compressibility profiles.
More info >>

 
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement